"Anti-Ulcer Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.
| Descriptor ID |
D000897
|
| MeSH Number(s) |
D27.505.954.483.203
|
| Concept/Terms |
Anti-Ulcer Agents- Anti-Ulcer Agents
- Agents, Anti-Ulcer
- Anti Ulcer Agents
- Anti-Ulcer Drugs
- Anti Ulcer Drugs
- Drugs, Anti-Ulcer
|
Below are MeSH descriptors whose meaning is more general than "Anti-Ulcer Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Ulcer Agents".
This graph shows the total number of publications written about "Anti-Ulcer Agents" by people in this website by year, and whether "Anti-Ulcer Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Ulcer Agents" by people in Profiles.
-
Wolf GT, Liu S, Bellile E, Sartor M, Rozek L, Thomas D, Nguyen A, Zarins K, McHugh JB. Tumor infiltrating lymphocytes after neoadjuvant IRX-2 immunotherapy in oral squamous cell carcinoma: Interim findings from the INSPIRE trial. Oral Oncol. 2020 12; 111:104928.
-
Butler JR, Rogers T, Eckart G, Martens GR, Ceppa EP, House MG, Nakeeb A, Schmidt CM, Zyromski NJ. Is antisecretory therapy after pancreatoduodenectomy necessary? Meta-analysis and contemporary practices of pancreatic surgeons. J Gastrointest Surg. 2015 Apr; 19(4):604-12.
-
Carey KM, Cross JE, Silva MA, Stefan MS, Rothberg MB. Pharmacy student impact on inappropriate prescribing of acid suppressive therapy. Am J Pharm Educ. 2011 Nov 10; 75(9):175.
-
Hussain S, Stefan M, Visintainer P, Rothberg M. Why do physicians prescribe stress ulcer prophylaxis to general medicine patients? South Med J. 2010 Nov; 103(11):1103-10.
-
Lee CW, Rickman B, Rogers AB, Ge Z, Wang TC, Fox JG. Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res. 2008 May 01; 68(9):3540-8.
-
Micalizzi M, Fraga P, Meng X. Comparative tolerability of 2- and 15-minute intravenous infusions of pantoprazole. Am J Health Syst Pharm. 2007 Sep 01; 64(17):1822-6.
-
Bochenek WJ, Peters S, Fraga PD, Wang W, Mack ME, Osato MS, El-Zimaity HM, Davis KD, Graham DY. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter. 2003 Dec; 8(6):626-42.
-
Ofman JJ, Segal R, Russell WL, Cook DJ, Sandhu M, Maue SK, Lowenstein EH, Pourfarzib R, Blanchette E, Ellrodt G, Weingarten SR. A randomized trial of an acid-peptic disease management program in a managed care environment. Am J Manag Care. 2003 Jun; 9(6):425-33.
-
Pertusi RM, Godwin KS, House JK, Knebl JA, Alexander JH, Rubin BR, Forman MD. Gastropathy induced by nonsteroidal anti-inflammatory drugs: prescribing patterns among geriatric practitioners. J Am Osteopath Assoc. 1999 Jun; 99(6):305-10.
-
Hoffman JS, Katz LM, Cave DR. Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication. Aliment Pharmacol Ther. 1999 Apr; 13(4):503-6.